Bioatla Stock Technical Analysis

BCAB Stock  USD 0.17  0.10  37.04%   
As of the 3rd of February, Bioatla shows the Standard Deviation of 9.93, mean deviation of 6.74, and Risk Adjusted Performance of (0.12). Bioatla technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Bioatla Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Bioatla, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to BioatlaBioatla's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

Bioatla Analyst Consensus

Target PriceConsensus# of Analysts
10.0Strong Buy4Odds
Bioatla current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Bioatla analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Bioatla stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Bioatla, talking to its executives and customers, or listening to Bioatla conference calls.
Bioatla Analyst Advice Details
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bioatla. Projected growth potential of Bioatla fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Bioatla assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share
(1.07)
Quarterly Revenue Growth
0.316
Return On Assets
(1.05)
Return On Equity
(8.14)
The market value of Bioatla is measured differently than its book value, which is the value of Bioatla that is recorded on the company's balance sheet. Investors also form their own opinion of Bioatla's value that differs from its market value or its book value, called intrinsic value, which is Bioatla's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bioatla's market value can be influenced by many factors that don't directly affect Bioatla's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Bioatla's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Bioatla should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Bioatla's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.

Bioatla 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Bioatla's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Bioatla.
0.00
11/05/2025
No Change 0.00  0.0 
In 2 months and 31 days
02/03/2026
0.00
If you would invest  0.00  in Bioatla on November 5, 2025 and sell it all today you would earn a total of 0.00 from holding Bioatla or generate 0.0% return on investment in Bioatla over 90 days. Bioatla is related to or competes with Celularity, PolyPid, Annovis Bio, Reviva Pharmaceuticals, Evaxion Biotech, BioXcel Therapeutics, and Generation Bio. BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics f... More

Bioatla Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Bioatla's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Bioatla upside and downside potential and time the market with a certain degree of confidence.

Bioatla Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Bioatla's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Bioatla's standard deviation. In reality, there are many statistical measures that can use Bioatla historical prices to predict the future Bioatla's volatility.
Hype
Prediction
LowEstimatedHigh
0.010.1710.46
Details
Intrinsic
Valuation
LowRealHigh
0.010.1610.45
Details
Naive
Forecast
LowNextHigh
0.010.3210.61
Details
4 Analysts
Consensus
LowTargetHigh
9.1010.0011.10
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Bioatla. Your research has to be compared to or analyzed against Bioatla's peers to derive any actionable benefits. When done correctly, Bioatla's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Bioatla.

Bioatla February 3, 2026 Technical Indicators

Bioatla Backtested Returns

Bioatla secures Sharpe Ratio (or Efficiency) of -0.16, which signifies that the company had a -0.16 % return per unit of risk over the last 3 months. Bioatla exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Bioatla's Risk Adjusted Performance of (0.12), standard deviation of 9.93, and Mean Deviation of 6.74 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of -3.65, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Bioatla are expected to decrease by larger amounts. On the other hand, during market turmoil, Bioatla is expected to outperform it. At this point, Bioatla has a negative expected return of -1.65%. Please make sure to confirm Bioatla's treynor ratio, skewness, rate of daily change, as well as the relationship between the value at risk and accumulation distribution , to decide if Bioatla performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  -0.44  

Modest reverse predictability

Bioatla has modest reverse predictability. Overlapping area represents the amount of predictability between Bioatla time series from 5th of November 2025 to 20th of December 2025 and 20th of December 2025 to 3rd of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Bioatla price movement. The serial correlation of -0.44 indicates that just about 44.0% of current Bioatla price fluctuation can be explain by its past prices.
Correlation Coefficient-0.44
Spearman Rank Test-0.16
Residual Average0.0
Price Variance0.03
Bioatla technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Bioatla technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Bioatla trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Bioatla Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Normalized Average True Range is used to analyze tradable apportunities for Bioatla across different markets.

About Bioatla Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Bioatla on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Bioatla based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Bioatla price pattern first instead of the macroeconomic environment surrounding Bioatla. By analyzing Bioatla's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Bioatla's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Bioatla specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2025 2026 (projected)
Interest Debt Per Share0.01980.0188
Revenue Per Share0.260.2

Bioatla February 3, 2026 Technical Indicators

Most technical analysis of Bioatla help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Bioatla from various momentum indicators to cycle indicators. When you analyze Bioatla charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Bioatla February 3, 2026 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Bioatla stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

Complementary Tools for Bioatla Stock analysis

When running Bioatla's price analysis, check to measure Bioatla's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioatla is operating at the current time. Most of Bioatla's value examination focuses on studying past and present price action to predict the probability of Bioatla's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioatla's price. Additionally, you may evaluate how the addition of Bioatla to your portfolios can decrease your overall portfolio volatility.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Equity Valuation
Check real value of public entities based on technical and fundamental data